Mei‐Ping Kung

2.8k total citations
47 papers, 2.4k citations indexed

About

Mei‐Ping Kung is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mei‐Ping Kung has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Physiology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mei‐Ping Kung's work include Alzheimer's disease research and treatments (21 papers), Medical Imaging Techniques and Applications (12 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Mei‐Ping Kung is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Medical Imaging Techniques and Applications (12 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Mei‐Ping Kung collaborates with scholars based in United States, Taiwan and Japan. Mei‐Ping Kung's co-authors include Hank F. Kung, Zhi‐Ping Zhuang, Catherine Hou, Daniel Skovronsky, Virginia M.‐Y. Lee, John Q. Trojanowski, Bin Zhang, Mu, Masahiro Ono and Karl Plößl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Neuroscience.

In The Last Decade

Mei‐Ping Kung

47 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Ping Kung United States 25 1.3k 799 518 494 386 47 2.4k
Zhi‐Ping Zhuang United States 27 1.4k 1.1× 1.1k 1.3× 537 1.0× 549 1.1× 446 1.2× 42 2.9k
Karl Plößl United States 30 655 0.5× 567 0.7× 621 1.2× 797 1.6× 258 0.7× 52 2.5k
Catherine Hou United States 36 1.7k 1.3× 1.1k 1.4× 915 1.8× 873 1.8× 549 1.4× 93 3.9k
Guo-Feng Huang United States 10 1.7k 1.4× 606 0.8× 290 0.6× 555 1.1× 358 0.9× 10 2.5k
Mengchao Cui China 29 1.4k 1.1× 784 1.0× 330 0.6× 418 0.8× 419 1.1× 132 2.8k
Anna Katrin Szardenings United States 19 1.2k 0.9× 1.0k 1.3× 308 0.6× 484 1.0× 140 0.4× 27 2.7k
Hank F. Kung United States 33 629 0.5× 841 1.1× 840 1.6× 1.3k 2.7× 173 0.4× 113 3.3k
Mei‐Ping Kung United States 37 1.1k 0.9× 1.1k 1.4× 1.4k 2.7× 1.2k 2.4× 343 0.9× 96 3.9k
Dag Sehlin Sweden 33 1.6k 1.3× 1.3k 1.6× 418 0.8× 574 1.2× 404 1.0× 85 3.0k
Stina Syvänen Sweden 32 958 0.8× 1.1k 1.4× 569 1.1× 682 1.4× 257 0.7× 100 3.3k

Countries citing papers authored by Mei‐Ping Kung

Since Specialization
Citations

This map shows the geographic impact of Mei‐Ping Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ping Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ping Kung more than expected).

Fields of papers citing papers by Mei‐Ping Kung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Ping Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ping Kung. The network helps show where Mei‐Ping Kung may publish in the future.

Co-authorship network of co-authors of Mei‐Ping Kung

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Ping Kung. A scholar is included among the top collaborators of Mei‐Ping Kung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Ping Kung. Mei‐Ping Kung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Kuo‐Lun, Kun‐Ju Lin, Ing‐Tsung Hsiao, et al.. (2013). Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [18F]AV-45 Positron Emission Tomography in Chinese Population. PLoS ONE. 8(3). e58974–e58974. 44 indexed citations
2.
Qü, Wenchao, et al.. (2009). Iodophenyl tagged sphingosine derivatives: Synthesis and preliminary biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(13). 3382–3385. 5 indexed citations
3.
Balagopal, Lakshmi, Mei‐Ping Kung, Brian P. Lieberman, et al.. (2007). (R)-N-Methyl-3-(3-125I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters. Nuclear Medicine and Biology. 35(1). 43–52. 6 indexed citations
4.
Kung, Mei‐Ping, et al.. (2006). F-18 labeled PET agents for amyloid plaque imaging. NeuroImage. 31. T51–T51. 1 indexed citations
5.
Ono, Masahiro, Mamoru Haratake, Morio Nakayama, et al.. (2005). Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease. Nuclear Medicine and Biology. 32(4). 329–335. 23 indexed citations
6.
Zhuang, Zhi‐Ping, Mei‐Ping Kung, Catherine Hou, Karl Plöessl, & Hank F. Kung. (2005). Biphenyls labeled with technetium 99m for imaging β-amyloid plaques in the brain. Nuclear Medicine and Biology. 32(2). 171–184. 52 indexed citations
7.
Kung, Mei‐Ping, et al.. (2004). Development and Evaluation of Iodinated Tracers Targeting Amyloid Plaques for SPECT Imaging. Journal of Molecular Neuroscience. 24(1). 49–54. 16 indexed citations
8.
Kung, Mei‐Ping, Seok-Rye Choi, Catherine Hou, et al.. (2004). Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nuclear Medicine and Biology. 31(5). 533–541. 28 indexed citations
9.
Kung, Mei‐Ping, et al.. (2004). Characterization of IMPY as a potential imaging agent for ?-amyloid plaques in double transgenic PSAPP mice. European Journal of Nuclear Medicine and Molecular Imaging. 31(8). 1136–45. 64 indexed citations
10.
Kung, Mei‐Ping, Catherine Hou, Zhi‐Ping Zhuang, et al.. (2002). IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques. Brain Research. 956(2). 202–210. 175 indexed citations
11.
12.
Skovronsky, Daniel, Bin Zhang, Mei‐Ping Kung, et al.. (2000). In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Neurobiology of Aging. 21. 178–178. 6 indexed citations
13.
Xu, Yiming, Seok-Rye Choi, Mei‐Ping Kung, & Hank F. Kung. (1999). Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs. Nuclear Medicine and Biology. 26(7). 833–839. 9 indexed citations
14.
Mu, Mu, Mei‐Ping Kung, Karl Plößl, et al.. (1999). A simplified method to determine [99mTc]TRODAT-1 in human plasma. Nuclear Medicine and Biology. 26(7). 821–825. 2 indexed citations
15.
Kung, Mei‐Ping, et al.. (1996). Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells. Life Sciences. 60(2). 91–100. 7 indexed citations
16.
Burris, Kevin D., Mary A. Pacheco, Theresa M. Filtz, et al.. (1995). Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors. Neuropsychopharmacology. 12(4). 335–345. 27 indexed citations
17.
Zhuang, Zhi‐Ping, Mei‐Ping Kung, William P. Clarke, et al.. (1995). Synthesis of (+)‐(R)‐ and (−)‐(S)‐trans‐8‐hydroxy‐2‐[N‐n‐propyl‐N‐(3′‐iodo‐2′‐propenyl)] aminotetralin: New 5‐HT1A receptor ligands. Chirality. 7(6). 452–458. 5 indexed citations
18.
Canney, Daniel J., Mei‐Ping Kung, & Hank F. Kung. (1995). Amino- and amido-tetrabenazine derivatives: Synthesis and evaluation as potential ligands for the vesicular monoamine transporter. Nuclear Medicine and Biology. 22(4). 527–535. 10 indexed citations
19.
Kung, Mei‐Ping, Sumalee Chumpradit, Jeffrey Billings, & Hank F. Kung. (1992). 4-Iodotomoxetine: A novel ligand for serotonin uptake sites. Life Sciences. 51(2). 95–106. 19 indexed citations
20.
Kung, Mei‐Ping, Yau‐Kwan Ho, David Lalka, & Thomas J. Bardos. (1984). Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents.. PubMed. 44(10). 4602–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Ping Zhuang Breakdown of academic impact, for papers by Karl Plößl Breakdown of academic impact, for papers by Catherine Hou Breakdown of academic impact, for papers by Guo-Feng Huang Breakdown of academic impact, for papers by Mengchao Cui Breakdown of academic impact, for papers by Anna Katrin Szardenings Breakdown of academic impact, for papers by Hank F. Kung Breakdown of academic impact, for papers by Mei‐Ping Kung Breakdown of academic impact, for papers by Dag Sehlin Breakdown of academic impact, for papers by Stina Syvänen
Rankless by CCL
2026